Final analysis of time to subsequent disease progression/death in patients with metastatic enteropancreatic neuroendocrine tumours progressing under placebo and switched to lanreotide Autogel/depot 120mg in the CLARINET open-label extension
Pavel ME, Cwikla J, Wolin E, Phan A, Raderer M, Sedlackova E, Cadiot G, Capdevila J, Rindi G, Lombard-Bohas C, Liyanage N, Thanh TXM, Ruszniewski P, Caplin M (2018)
Publication Type: Conference contribution
Publication year: 2018
Journal
Book Volume: 41
Pages Range: 310-310
DOI: 10.1093/annonc/mdx368.023
Authors with CRIS profile
Involved external institutions
Mount Sinai Hospital (MSH)
Canada (CA)
Robert Debré Hospital for Mothers and Children / Hôpital Robert Debré pour la mère et l'enfant
France (FR)
Morehouse School of Medicine
United States (USA) (US)
Univerzita Karlova v Praze / Charles University in Prague
Czech Republic (CZ)
University of Warmia and Mazury in Olsztyn
Poland (PL)
Medizinische Universität Wien
Austria (AT)
Hospices Civils de Lyon (CHU)
France (FR)
Catholic University of the Sacred Heart / Università Cattolica del Sacro Cuore
Italy (IT)
Beaujon Hospital / Hôpital Beaujon
France (FR)
Ipsen Pharma
France (FR)
Royal Free Hospital
United Kingdom (GB)
Vall d'Hebron University Hospital / Hospital Universitari Vall d'Hebron
Spain (ES)
Canada (CA)
Robert Debré Hospital for Mothers and Children / Hôpital Robert Debré pour la mère et l'enfant
France (FR)
Morehouse School of Medicine
United States (USA) (US)
Univerzita Karlova v Praze / Charles University in Prague
Czech Republic (CZ)
University of Warmia and Mazury in Olsztyn
Poland (PL)
Medizinische Universität Wien
Austria (AT)
Hospices Civils de Lyon (CHU)
France (FR)
Catholic University of the Sacred Heart / Università Cattolica del Sacro Cuore
Italy (IT)
Beaujon Hospital / Hôpital Beaujon
France (FR)
Ipsen Pharma
France (FR)
Royal Free Hospital
United Kingdom (GB)
Vall d'Hebron University Hospital / Hospital Universitari Vall d'Hebron
Spain (ES)
How to cite
APA:
Pavel, M.E., Cwikla, J., Wolin, E., Phan, A., Raderer, M., Sedlackova, E.,... Caplin, M. (2018). Final analysis of time to subsequent disease progression/death in patients with metastatic enteropancreatic neuroendocrine tumours progressing under placebo and switched to lanreotide Autogel/depot 120mg in the CLARINET open-label extension. (pp. 310-310).
MLA:
Pavel, Marianne Ellen, et al. "Final analysis of time to subsequent disease progression/death in patients with metastatic enteropancreatic neuroendocrine tumours progressing under placebo and switched to lanreotide Autogel/depot 120mg in the CLARINET open-label extension." 2018. 310-310.
BibTeX: Download